Highlights Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
60.51 ^CNY	-0.31%		-6.43%	+15.59%

Apr. 22	Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 18	China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Xiamen Amoytop Biotech Gets Nod to Market Hepatitis Drug; Shares Up 4%	Mar. 18	MT
Amoytop Biotech's 2023 Profit Jumps 93%	Feb. 26	MT
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Amoytop Biotech Signs Exclusive License Deal for Liver Disease Drug With Alphamab Unit	Dec. 07	MT
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-19	CI
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Amoytop Biotech Signs Exclusive Commercialization Deal With Fosun Unit	23-06-01	MT
Aligos Therapeutics to Collaborate with Xiamen Amoytop Biotech on Liver Disease Treatments; Aligos Shares Jump	23-05-15	MT
Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co. Ltd. for Use of Aligos' Oligonucleotide Platform for the Treatment of Liver Diseases	23-05-12	CI
Amoytop Biotech to Co-Develop Hepatitis Treatment With US-Based Aligos	23-05-12	MT
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Amoytop Biotech Gets Regulatory Nod for Anti-COVID-19 Spray Trial	23-01-10	MT
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-18	CI
Guangzhou Houbao Investment Partnership Enterprise (Limited Partnership) completed the acquisition of a 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. from Tonghua Dongbao Pharmaceutical Co., Ltd..	22-05-18	CI
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Guangzhou Houbao Investment Partnership (Limited Partnership) signed a share transfer agreement to acquire 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. from Tonghua Dongbao Pharmaceutical Co., Ltd. for approximately CNY 410 million.	22-03-17	CI
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

Highlights

Filters